Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B7636 VU 0357017 hydrochlorideSummary: Positive allosteric modulator of muscarinic M1 receptors
- B7652 A 582941Summary: partial agonist of α7 nicotinic acetylcholine receptors
- B7653 Ro 67-4853Summary: Positive allosteric modulator of mGlu group I receptors
- B7654 Ro 01-6128Summary: Positive allosteric modulator of mGlu1 receptors
- B7655 JHW 007 hydrochlorideSummary: Dopamine uptake inhibitor
- B7668 VU 29Summary: mGlu5 allosteric potentiator
- B7677 NCX 4040Summary: COX-2 expression inhibitor
- B7698 A 331440 dihydrochlorideSummary: H3 receptor antagonist,non-imidazole,high affinity
- B7710 SIB 1508Y maleateSummary: neuronal nicotinic ACh receptor agonist
- B7724 LY 2389575 hydrochlorideSummary: negative allosteric modulator of mGlu3